Hosted on MSN1mon
Could a pill replace gene therapy for sickle cell disease? Research uncovers potential path to small-molecule drugCasgevy works by enabling people to produce a fetal form of hemoglobin that doesn't cause sickling. It does so by suppressing the gene BCL11A, which normally shuts down fetal hemoglobin production ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback